<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>2025</volume><submitter>Toledo L</submitter><funding>Fundação de Amparo à Pesquisa do Estado de Minas Gerais</funding><funding>Conselho Nacional de Desenvolvimento Científico e Tecnológico</funding><funding>Coordenação de Aperfeiçoamento de Pessoal de Nível Superior</funding><journal>Transboundary and emerging diseases</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12377971</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Use of Subtherapeutic Tylvalosin Against Mycoplasma hyopneumoniae: Implications For Respiratory Microbiome Dysbiosis and Swine Lung Health</pubmed_title><pmcid>PMC12377971</pmcid><pubmed_authors>Marks F</pubmed_authors><pubmed_authors>Simao G</pubmed_authors><pubmed_authors>Moreira M</pubmed_authors><pubmed_authors>Pereira C</pubmed_authors><pubmed_authors>Diamantino C</pubmed_authors><pubmed_authors>Polveiro R</pubmed_authors><pubmed_authors>Toledo L</pubmed_authors><pubmed_authors>Costa E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Use of Subtherapeutic Tylvalosin Against Mycoplasma hyopneumoniae: Implications For Respiratory Microbiome Dysbiosis and Swine Lung Health</name><description/><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Jan</publication><modification>2026-05-09T17:56:51.307Z</modification><creation>2026-04-08T01:07:21.718Z</creation></dates><accession>S-EPMC12377971</accession><cross_references/></HashMap>